Travis Steed

“At TCT in a couple weeks, you've got Amulet 360 pivotal data and coronary IVL pivotal data. Just curious if anything you'd say on that and then, you know, how quickly those products can launch.”

“And Jay, we'll miss working with you and best of luck in your new role. I wanted to ask about inflation impact on margins, anything you'd kind of call out or quantify this quarter.”

“And I guess as we move into the second half of this year, investors are going to start looking more into next year. Just curious how you think about the Abbott portfolio in the next year.”

“Maybe at a higher level, just curious how you think about considering all avenues for shareholder value creation and kind of balanced risk-adjusted shareholder returns versus going to kind of your longer-term strategic plan.”

“I guess looking ahead a little bit, obviously the TSAs are going to offset a lot of the one-time stuff for probably, what, two years. But once those go away, do you have enough kind of juice in the bag, I guess, to continue to expand margins, you know, once the TSAs go away in a couple years?”